Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $117
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Matthew Gillmor maintains an Overweight rating on Encompass Health (NYSE:EHC) and raises the price target from $115 to $117.
October 29, 2024 | 11:58 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Keybanc analyst Matthew Gillmor has maintained an Overweight rating on Encompass Health and increased the price target from $115 to $117, indicating a positive outlook.
The increase in price target from $115 to $117 by Keybanc suggests a positive outlook for Encompass Health, likely leading to a short-term positive impact on the stock price. The Overweight rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100